Literature DB >> 10984138

The coexistence of Behçet's disease and ankylosing spondylitis.

P Borman1, H Bodur, G Ak, E E Bostan, N Barça.   

Abstract

We present the case of a young woman suffering from both ankylosing spondylitis and Behçet's disease, associated with a severe inflammatory arthritis. Although the HLA phenotype was positive for HLA-B27 and negative for HLA-B5, the clinical findings, especially the joint manifestations of Behçet's disease, seem to appear dominantly. The meaning of this rare combination was discussed with a review of the literature.

Entities:  

Mesh:

Year:  2000        PMID: 10984138     DOI: 10.1007/s002960000052

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  5 in total

Review 1.  Erosive arthritis in a patient with Behçet's disease.

Authors:  Nurşen Düzgün; Aşkin Ateş
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

Review 2.  Coexisting Behçet's disease and ankylosing spondylitis presented with deep venous thrombosis: a case report and review of the literature.

Authors:  Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

Review 3.  Ankylosing spondylitis: Chinese perspective, clinical phenotypes, and associated extra-articular systemic features.

Authors:  Huei-Huang Ho; Ji-Yih Chen
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

4.  Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis.

Authors:  Necmettin Yildiz; Hakan Alkan; Fusun Ardic; Oya Topuz
Journal:  Rheumatol Int       Date:  2009-08-25       Impact factor: 2.631

5.  Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study.

Authors:  Hsin-Hua Chen; Wen-Cheng Chao; Yi-Hsing Chen; Tsu-Yi Hsieh; Kuo-Lung Lai; Yi-Ming Chen; Wei-Ting Hung; Ching-Tsai Lin; Chih-Wei Tseng; Ching-Heng Lin
Journal:  Arthritis Res Ther       Date:  2019-08-29       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.